Data is currently being updated. Some features may be temporarily unstable.

Disease Profile

Viral

Mumps

流行性腮腺炎

Mumps is a viral infection of the salivary glands, classified in ICD-10 as B26 and in ICD-11 as KA62. The source payload contains only limited disease-specific clinical and epidemiologic detail, so a conservative profile is warranted [1][2][3]. Source-backed detail on transmission, prevention, and surveillance interpretation is not yet available in the provided snippets [1][2][3].

Definition

Mumps is identified in the provided metadata as a viral infection of the salivary glands [disease]. The disease is indexed as B26 in ICD-10 and KA62 in ICD-11, which supports its use as a standardized surveillance entity [disease]. No additional etiologic characterization, such as viral subtype or pathogenesis, is stated in the source snippets and is therefore not added here [1][2][3].

Clinical features

The supplied sources do not describe the clinical syndrome of mumps in detail, beyond identifying it as a salivary-gland infection [disease]. Source-backed information on symptom sequence, severity spectrum, complications, duration, or post-infectious sequelae is not available in the provided material [1][2][3]. Accordingly, this profile does not infer typical clinical features from general medical knowledge.

Epidemiology

The provided sources do not report geographic distribution, outbreak patterns, reservoir, seasonality, or burden estimates for mumps [1][2][3]. One source is a bibliographic citation for a 2000 article titled “Mumps and mumps vaccine,” but the snippet supplies only scholarly metadata rather than epidemiologic findings [1]. Another metadata record identifies a 2005 encyclopedia entry on mumps, and a third identifies a 1995 childhood-conditions reference, but neither snippet provides usable population-level epidemiology [2][3].

Transmission

Source-backed information on how mumps is transmitted is not present in the provided snippets [1][2][3]. Because the evidence boundary here is limited to metadata and unrelated vaccine-safety material, no transmission route or exposure mechanism is asserted [4][5][6].

Risk groups

The provided snippets do not identify specific high-risk groups for mumps infection or severe outcomes [1][2][3]. Vaccine-safety sources discuss MMR use in children and note analyses in high-risk children with siblings who have autism, but that evidence concerns autism outcomes rather than mumps susceptibility [4][5][6]. Source-backed detail on age, pregnancy, immunocompromise, or other risk strata is not yet available in the supplied material.

Prevention

The source set does not provide mumps-specific prevention guidance, immunization schedule details, or outbreak-control measures [1][2][3]. The only vaccine-related material concerns MMR safety in relation to autism, including high-strength evidence of no increased autism risk after MMR vaccination and increased risk of febrile seizures with MMR in children [5]. This evidence supports the broader context of vaccine confidence, but it does not itself provide mumps prevention guidance in the snippet set [4][5][6].

Surveillance note

For surveillance purposes, the most reliable identifier available here is the disease classification itself: mumps as a viral salivary-gland infection, ICD-10 B26 and ICD-11 KA62 [disease]. The current source packet does not provide case definitions, laboratory criteria, or reporting thresholds, so those elements should be obtained from a dedicated surveillance manual rather than inferred [1][2][3]. Vaccine-safety literature included in the payload addresses autism concerns around MMR and may be useful for communication context, but it does not substitute for disease monitoring guidance [4][5][6].

References
  1. 1 Mumps and mumps vaccine. The Indian Journal of Pediatrics. 2000. doi: 10.1007/bf02859472. DOI: https://doi.org/10.1007/bf02859472
  2. 2 Mumps. Van Nostrand's Scientific Encyclopedia. 2005. doi: 10.1002/0471743984.vse5025. DOI: https://doi.org/10.1002/0471743984.vse5025
  3. 3 Mumps. The A-Z Reference Book of Childhood Conditions. 1995. doi: 10.1007/978-1-4899-7098-5_29. DOI: https://doi.org/10.1007/978-1-4899-7098-5_29
  4. 4 DeStefano F et al. The MMR Vaccine and Autism. Annu Rev Virol. 2019 Sep 29. PMID: 30986133. doi: 10.1146/annurev-virology-092818-015515. PubMed: https://pubmed.ncbi.nlm.nih.gov/30986133/
  5. 5 Gidengil C et al. Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis. Vaccine. 2021 Jun 23. PMID: 34049735. doi: 10.1016/j.vaccine.2021.03.079. PubMed: https://pubmed.ncbi.nlm.nih.gov/34049735/
  6. 6 Mohammed SA et al. Does Vaccination Increase the Risk of Autism Spectrum Disorder? Cureus. 2022 Aug. PMID: 36110492. doi: 10.7759/cureus.27921. PubMed: https://pubmed.ncbi.nlm.nih.gov/36110492/
Coding Register
ICD-10
B26
ICD-11
KA62
Key Statistics
Total cases
4.5M
Total deaths
27
Peak month
2012-06
Coverage
8 reporting countries · 2000-01-01 → 2026-06-20

Figure 1 | Full historical trajectories across all reporting countries.

Figure 2 | Year-over-year monthly comparison for seasonality and structural shifts.

Dataset Archive

Supplementary Data | Multi-country disease dataset

Machine-readable multi-country disease dataset (JSON/CSV) with source metadata.

Rows
2,706
Data Version
2026-06-20
Coverage
Included metadata
Source links, scope, cadence

Source Register

Official sources and update cadences used to construct the downloadable dataset.

AU
Australia NINDSSmonthlymicrosoft_bi

Australia

Australian national notifiable diseases surveillance dashboard.

Official source
CN
China CDC WeeklyMONTHLYweb

China

Monthly notifiable infectious disease reports published by China CDC.

Official source
CN
National Disease Control and Prevention AdministrationMONTHLYweb

China

Official China public health bulletin and query portal.

Official source
CN
PubMedMONTHLYweb

China

Biomedical literature discovery feed used as supplementary context.

Official source
HK
Hong Kong, China CHP Notifiable Diseasesmonthlyopen_data_csv

Hong Kong, China

Hong Kong, China CHP annual notifiable infectious disease CSVs normalized to national monthly totals

Official source
JP
JP NIID Weeklyweeklyweb

Japan

Japan weekly infectious disease surveillance via NIID/JIHS.

Official source
KR
Korea KDCA EIDmonthlyopen_api_or_portal_download

South Korea

Korea KDCA notifiable infectious disease OpenAPI or portal/KOSIS downloads aggregated to national monthly notification counts.

Official source
NZ
phf_monthlymonthlyweb

New Zealand

PHF Science (formerly ESR) monthly notifiable disease surveillance data via internal globalID2 crawler

Official source
TW
Taiwan, China CDC NIDSSmonthlyopen_data_csv

Taiwan, China

Taiwan, China monthly notifiable infectious disease open-data CSV feed.

Official source
US
US CDC NNDSSweeklyapi

United States

CDC National Notifiable Diseases Surveillance System provisional data.

Official source
Suggested presentation pattern: cite the data version and coverage window when exporting charts or tables for publication.